Hemorrhagic complications are frequent and clinically significant in patients undergoing mechanical circulatory support (MCS), occurring in 10% to 40% of cardiogenic shock cases and 5% to 10% of high-risk percutaneous coronary interventions. These events prolo... ...

请注册登录后继续浏览